Journal of Clinical Epidemiology
Volume 52, Issue 9 , Pages 849-860 , September 1999

The Repeatability of Three Methods for Measuring Prospective Patients' Values in the Context of Treatment Choice for End-Stage Renal Disease

  • Patti A. Groome

      Affiliations

    • Departments of Oncology and of Community Health and Epidemiology and the Radiation Oncology Research Unit, Queen's University, Kingston, Ontario, Canada
    • Corresponding Author InformationAddress correspondence to: Dr. Patti Groome, Radiation Oncology Research Unit, Kingston General Hospital, Apps Level 4, Kingston, Ontario, Canada K7L 2V7
    • ,
  • Tom A. Hutchinson

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
    • ,
  • Pierre Tousignant

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
    • ,
  • James A. Hanley

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

,Accepted 30 March 1999.

References 

  1. Charytan C, Spinowitz BS, Gallen M. A comparative study of continuous ambulatory peritoneal dialysis and center hemodialysis. Arch Intern Med. 1986;146:1138–1143
  2. Seedat YK, MacIntosh CG, Subban JV. Quality of life for patients in an end-stage renal disease programme. S Afr Med. 1987;71:500–504
  3. Morris PL, Jones B. Life satisfaction across treatment methods for patients with end-stage renal failure. Med J Aust. 1989;150:428–432
  4. Oberley ET, Schatell DR. Home hemodialysis (Survival, quality of life, and rehabilitation). Adv Ren Replace Ther. 1996;3:147–153
  5. Friedman EA. Management choices in diabetic end-stage renal disease. Nephrol Dial Transplant. 1995;10:61–69
  6. Becker BN, Stone WJ. Options for renal replacement therapy (Special considerations). Semin Nephrol. 1997;17:176–187
  7. Kaplan de-Nour A, Shanan J. Quality of life of dialysis and transplanted patients. Nephron. 1980;25:117–120
  8. Kalman TP, Wilson PG, Kalman LM. Psychiatric morbidity in long-term renal transplant recipients and patients undergoing hemodialysis (A comparative study). JAMA. 1983;250:55–58
  9. Vollmer WM, Wahl PW, Blagg CR. Survival with dialysis and transplantation in patients with end-stage renal disease. N Engl J Med. 1983;308:1553–1558
  10. Hutchinson TA, Thomas DB, Lemieux JC, Harvey CE. Prognostically controlled comparison of dialysis and renal transplantation. Kidney Int. 1984;26:44–51
  11. Kutner NG, Brogan D, Kutner MH. End-stage renal disease treatment modality and patients' quality of life. Am J Nephrol. 1986;6:396–402
  12. Hart LG, Evans RW. The functional status of ESRD patients as measured by the Sickness Impact Profile. J Chron Dis. 1987;40:117s–130s
  13. Oldenburg B, Macdonald GJ, Perkins RJ. Prediction of quality of life in a cohort of end-stage renal disease patients. J Clin Epidemiol. 1988;41:555–564
  14. Christensen AJ, Holman JM, Turner CW, Slaughter JR. Quality of life in end-stage renal disease (Influence of renal transplantation). Clin Transpl. 1989;3:46–53
  15. Deniston LF, Carpentier-Alting P, Kneisley J, Hawthorne VM, Port FK. Assessment of quality of life in end-stage renal disease. Health Serv Res. 1989;24:555–578
  16. Julius M, Kneisley JD, Carpentier-Alting P, Hawthorne VM, Wolfe RA, Port FK. A comparison of employment rates of patients treated with continuous abulatory peritoneal dialysis versus in-center hemodialysis (Michigan end-stage renal disease study). Arch Intern Med. 1989;149:839–842
  17. Griffin KW, Wadwa NK, Friend R, Suh H, Howell N, Cabralda T, et al.  Comparison of quality of life in hemodialysis and peritoneal dialysis patients. Adv Perit Dial. 1994;10:104–108
  18. Nissenson AR. Measuring, managing, and improving quality in the end-stage renal disease treatment setting (Peritoneal dialysis). Am J Kidney Dis. 1994;24:368–375
  19. Maiorca R, Cancarini GC, Brunori G, Zubani R, Camerini C, Manili L, et al.  Comparison of long-term survival between hemodialysis and peritoneal dialysis. Adv Perit Dial. 1996;12:79–88
  20. Maiorca R, Cancarini GC, Brunori G, Zubani R, Camerini C, Manili L, et al.  Which treatment for which patient in the future? Possible modifications in CAPD. Nephrol Dial Transplant. 1995;10:20–26
  21. Kurtin P, Nissenson AR. Variation in end-stage renal disease patient outcomes (What we know, what should we know, and how do we find out?). J Am Soc Nephrol. 1993;3:1738–1747
  22. Szabo E, Moody H, Hamilton T, Ang C, Kovithavongs C, Kjellstrand C. Choice of treatment improves quality of life (A study on patients undergoing dialysis). Arch Intern Med. 1997;157:1352–1356
  23. Weinstein MC, Fineberg HV. Utility analysis (clinical decisions involving many possible outcomes). In:  Weinstein MC,  Fineberg HV editor. Clinical Decision Analysis. Philadelphia: W.B. Saunders; 1980;
  24. Eraker SA, Polister P. How decisions are reached (Physician and patient). Ann Intern Med. 1982;97:262–268
  25. Doubilet P, McNeil BJ. Clinical decision making. Med Care. 1985;23:648–662
  26. Feinstein AR. Clinical biostatistics (xxxix. The hayes of Bayes, the aerial palaces of decision analysis, and the computerized Ouija board). Clin Pharmacol Ther. 1977;21:482–496
  27. Polister P. Decision analysis and clinical judgement (A re-evaluation). Med Decis Making. 1981;1:361–389
  28. Cebul RD. “A look at the chief complaints” revisited (Current obstacles and opportunities for decision analysis). Med Decis Making. 1984;4:271–283
  29. Hershey JC, Kunreuther HC, Shoemaker PJH. Sources of bias in assessment procedures for utility functions. Manage Sci. 1982;28:936–954
  30. Kassirer JP, Moskowitz AJ, Lau J, Pauker SG. Decision analysis (A progress report). Ann Intern Med. 1987;106:275–291
  31. Health Services Research Group . Studying patients' preferences in health care decision making. Can Med Assoc J. 1992;147:859–864
  32. Froberg DG, Kane RL. Methodology for measuring health-state preferences—IV (Progress and a research agenda). J Clin Epidemiol. 1989;42:675–685
  33. vonNeumann J, Morgenstern O. Theory of Games and Economic Behavior. 3rd Edition. Princeton: Princeton University; 1953;
  34. Torrance GW. A Generalized Cost-Effectiveness Model for the Evaluation of Health Programs. (Dissertation). Buffalo: State University of New York; 1971;
  35. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales (A critical view). Psychol Med. 1988;18:1007–1019
  36. Groome PA. Measuring Prospective Patients' Values for Treatments for End-Stage Renal Disease. (Dissertation). Department of Epidemiology and Biostatistics, Montreal: McGill University; 1994;
  37. Hazen GB, Hopp WJ, Pellissier JM. Continuous risk assessment in medical decision making. Med Decis Making. 1991;11:194–304
  38. Groome PA, Hutchinson TA, Tousignant P. Content of a decision analysis for treatment choice in end-stage renal disease (Who should be consulted?). Med Decis Making. 1994;14:91–97
  39. Baxter Health Care Corporation. Choices: Options for living with kidney failure. Videotape. 1989.
  40. Andrews FM, Withey SB. Social Indicators of Well-Being (American's Perceptions of Life Quality). New York: Plenum; 1976;
  41. Stevens SS. A metric for the social concensus. Science. 1996;151:530–541
  42. Stevens SS. Issues in psychophysical measurement. Psychol Rev. 1971;78:426–450
  43. Donner A, Eliasziw M. Sample size requirements for reliability studies. Stat Med. 1987;6:441–448
  44. Altman DG, Bland JM. Measurement in medicine (The analysis of method comparison studies). Statistician. 1983;32:307–317
  45. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310
  46. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd Edition. Hillsdale, NJ: Lawrence Erlbaum; 1988;
  47. DBase IV. Computer software. Culver City, CA: Ashton-Tate; 1990.
  48. PC-SAS Release 6.04. Computer Software. Cary, NC: SAS Institute Inc.; 1987.
  49. Colton T. Statistics in Medicine. Boston: Little, Brown and Company; 1974;
  50. Krantz DS, Baum A, Wideman MV. Assessment of preferences for self-treatment and information in health care. J Pers Soc Psychol. 1980;39:977–990
  51. Strull WM, Lo B, Charles G. Do patients want to participate in medical decision making?. JAMA. 1984;252:2990–2994
  52. Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients' desire for autonomy (Decision making and information-seeking preferences among medical patients). J Gen Intern Med. 1989;1:29–39
  53. Sutherland HJ, Llewellyn-Thomas HA, Lockwood GA, Tritchler DL, Till JE. Cancer patients (Their desire for information and participation in treatment decisions). J R Soc Med. 1989;82:260–263
  54. Degner LF, Sloan JA. Decision making during serious illness (What role do patients really want to play?). J Clin Epidemiol. 1992;45:941–950
  55. Jamieson MJ, Webster J, Philips S, Jeffers A, Scott AK, Robb OJ, et al.  The measurement of blood pressure (Sitting or supine, once or twice?). J Hypertens. 1990;8:635–640
  56. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chron Dis. 1978;31:697–704
  57. Churchill DN, Torrance GW, Taylor DW. Measurement of quality of life in end-stage renal disease (the time trade-off approach). Clin Invest Med. 1987;10:14–20
  58. Russell JD, Beecroft ML, Ludwin D, Churchill DN. The quality of life in renal transplantation—a prospective study. Transplantation. 1992;54:656–660
  59. Sesso R, Yoshihiro MM. Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial Transplant. 1997;12:2111–2116
  60. Torrance GW. Social preferences for health states (An empirical evaluation of three measurement techniques). Socio-Econ Plan Sci. 1976;10:129–136
  61. Rutten-van Molken MPMH, Bakker CH, van Doorslaer EKA, van der Linden S. Methodological issues of patient utility measurement experience from two clinical trials. Med Care. 1995;33:922–937
  62. Churchill DN, Morgan J, Torrance GW. Quality of life in end-stage renal disease. Periton Dial Bull. 1984;4:20–23
  63. Llewellyn-Thomas HA, Sutherland HJ, Ciampi A, Etezadi-Amoli J, Boyd NF, Till JE. The assessment of values in laryngeal cancer (Reliability of measurement methods). J Chron Dis. 1984;37:283–291
  64. Mohide EA, Torrance GW, Streiner DL, Pringle DM, Gilbert R. Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol. 1988;41:475–482
  65. O'Connor A. Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol. 1989;42:119–126
  66. Sutherland HJ, Lockwood GA, Minkin S, Tritchler DL, Till JE, Llewellyn-Thomas HA. Measuring satisfaction with health care (A comparison of single with paired rating strategies). Soc Sci Med. 1989;28:53–58
  67. Boyd NF, Sutherland HJ, Heasman KZ, Tritchler DL, Cummings BJ. Whose utilities for decision analysis?. Med Decis Making. 1990;10:58–67
  68. Kramer MS, MacLellan A, Ciampi A, Etezadi-Amoli J, Leduc DG. Parents' vs physicians' utilities (values) for clinical outcomes in potentially bacteremic children. J Clin Epidemiol. 1990;43:1319–1325
  69. Mehrez A, Gafni A. The healthy-years equivalents (How to measure them using the standard gamble approach). Med Decis Making. 1991;11:140–146
  70. O'Connor AM, Davies BL, Dulberg CS, Buhler PL, Nadon C, Hastings-McBride B, et al.  Psychometric properties of health risk attitude measures in predicting cessation among pregnant smokers. Med Care. 1993;31:658–662
  71. O'Brien B, Viramontes JL. Willingness to pay (A valid and reliable measure of health state preference?). Med Decis Making. 1994;14:289–297
  72. Clarke AE, Goldstein MK, Michelson D, Garber AM, Lenart LA. The effect of assessment method and respondent population on utilities elicited for Gaucher Disease. Qual Life Res. 1997;6:169–184
  73. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40:593–600
  74. Feeny DH, Torrence GW. Incorporating utility-based quality-of-life assessment measures in clinical trials (two examples). Med Care. 1989;27:S190–S204
  75. Llewellyn-Thomas HA, Thiel EC, McGreal MJ. Cancer patients' evaluations of their current health states (The influence of expectations, comparisons, actual health status, and mood). Med Decis Making. 1992;12:115–122
  76. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ. 1996;313:41–42
  77. Streiner DL, Norman GR. Health Measurement Scales (A Practical Guide to Their Development and Use). 2nd Edition. Oxford, New York, Tokyo: Oxford University Press; 1995;
  78. von Winterfeldt D, Edwards W. Decision Analysis and Behavioral Research. Cambridge, MA: Cambridge University Press; 1986;
  79. Nord E. Methods for quality of adjustment of life years. Soc Sci Med. 1992;34:559–569
  80. Torrance GW. Health index and utility models (Some thorny issues). Health Serv Res. 1973;8:12–14
  81. Froberg DG, Kane RL. Methodology for measuring health-state preferences—I (measurement strategies). J Clin Epidemiol. 1989;42:345–354
  82. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res. 1997;29:21–43
  83. Ross CK, Steward CA, Sinacore JM. The importance of patient preferences in the measurement of health care satisfaction. Med Care. 1993;12:1138–1149
  84. Kassirer JP. Adding insult to injury (usurping patients' prerogatives). N Engl J Med. 1983;308:898–901
  85. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes (Comparisons of assessment methods). Med Decis Making. 1984;4:315–329
  86. O'Connor AM. Consumer/patient decision support in the new millennium (Where should our research take us? [editorial]). Can J Nurs Res. 1997;29:7–19
  87. Brundage MD, Davidson JR, Mackillop WJ, Feldman-Stewart D, Groome PA. Using a treatment-tradeoff method to elicit preferences for the treatment of locally advanced non-small-cell lung cancer. Med Decis Making. 1998;18:256–267
  88. Llewellyn-Thomas HA. Investigating patients' preferences for different treatment options. Can J Nurs Res. 1997;29:45–64
  89. Whelan TJ, Levine MN, Gafni A, Lukka H, Mohide EA, Patel M, et al.  Breast irradiation postlumpectomy (Development and evaluation of a decision instrument). J Clin Oncol. 1995;13:847–853
  90. Brundage MD, Cosby RH, Feldman-Stewart D, Gregg R, Dixon P, Youssef Y, et al.  Pilot study of a decision aid for patients with locally-advanced non-small cell lung cancer (LA-NSCLC). Med Decis Making. 1998;18:483;(Abstract)
  91. Molenaar S, Sprangers P, Oosterveld P, de Haes JC. The evaluation of an interactive computer programme on treatment options in early stage breast cancer (Preliminary results). Med Decis Making. 1998;18:482;(Abstract)
  92. Goel V, Sawka CA, Thiel EC, Gort E, O'Connor A. A randomized trial of a decision aid for breast cancer surgery. Med Decis Making. 1998;18:482;(Abstract)
  93. O'Connor AM, Llewellyn-Thomas HA, Sawka CA, Pinfold SP, To T, Harrison DE. Physicians' opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer. Patient Educ Counsel. 1997;30:143–153
  94. Levine MN, MacFarlane D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med. 1992;117:53–58
  95. O'Connor A, Tugwell P, Wells G, Elmslie T. Do decision aids help postmenopausal women considering preventive hormone replacement therapy (HRT)?. Med Decis Making. 1995;15:433;(Abstract)

PII: S0895-4356(99)00072-4

Journal of Clinical Epidemiology
Volume 52, Issue 9 , Pages 849-860 , September 1999

Article Tools

* Image Usage & Resolution